{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:44:20Z","timestamp":1789911860749,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Intensive Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jointm.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T23:13:40Z","timestamp":1648941220000},"page":"150-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Beta-blockers in septic shock: What is new?"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-5356","authenticated-orcid":false,"given":"Mickael","family":"Lescroart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3565-1818","authenticated-orcid":false,"given":"Benjamin","family":"Pequignot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Kimmoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7630-2908","authenticated-orcid":false,"given":"Bruno","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jointm.2022.01.004_bib0001","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/0885066609340519","article-title":"Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress","volume":"24","author":"D\u00fcnser","year":"2009","journal-title":"J Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.01.004_bib0002","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","article-title":"Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach","volume":"160","author":"Annane","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/SHK.0000000000001046","article-title":"Baroreflex sensitivity and blood pressure variability can help in understanding the different response to therapy during acute phase of septic shock","volume":"50","author":"Carrara","year":"2018","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.jointm.2022.01.004_bib0004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00000658-196110000-00011","article-title":"Studies on hemorrhagic and endotoxin shock in relation to vasomotor changes and endogenous circulating epinephrine, norepinephrine and serotonin","volume":"154","author":"Rosenberg","year":"1961","journal-title":"Ann Surg"},{"issue":"9588","key":"10.1016\/j.jointm.2022.01.004_bib0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine vs. epinephrine alone for management of septic shock: a randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jointm.2022.01.004_bib0006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0885066616689548","article-title":"Misdirected sympathy: the role of sympatholysis in sepsis and septic shock","volume":"33","author":"Ferreira","year":"2018","journal-title":"J Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0007","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s13054-016-1488-x","article-title":"Decatecholaminisation during sepsis","volume":"20","author":"Rudiger","year":"2016","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jointm.2022.01.004_bib0008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000339271","article-title":"Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application","volume":"122","author":"Wachter","year":"2012","journal-title":"Cardiology"},{"issue":"3\u20134","key":"10.1016\/j.jointm.2022.01.004_bib0009","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ando.2020.03.012","article-title":"Adrenergic receptors and cardiovascular effects of catecholamines","volume":"82","author":"Motiejunaite","year":"2021","journal-title":"Ann Endocrinol"},{"issue":"9","key":"10.1016\/j.jointm.2022.01.004_bib0010","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1097\/CCM.0000000000001078","article-title":"\u03b21-adrenergic inhibition improves cardiac and vascular function in experimental septic shock","volume":"43","author":"Kimmoun","year":"2015","journal-title":"Crit Care Med"},{"issue":"8","key":"10.1016\/j.jointm.2022.01.004_bib0011","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1007\/s00134-011-2236-y","article-title":"Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock","volume":"37","author":"Aboab","year":"2011","journal-title":"Intensive Care Med"},{"issue":"10","key":"10.1016\/j.jointm.2022.01.004_bib0012","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1097\/01.CCM.0000182796.11329.3B","article-title":"Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats","volume":"33","author":"Suzuki","year":"2005","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0013","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-016-1419-x","article-title":"Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock","volume":"20","author":"Hern\u00e1ndez","year":"2016","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.jointm.2022.01.004_bib0014","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ALN.0000000000003045","article-title":"Heart rate control during experimental sepsis in mice: comparison of ivabradine and \u03b2-blockers","volume":"132","author":"Bedet","year":"2020","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.jointm.2022.01.004_bib0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00134-011-2326-x","article-title":"Beta-1 blocker improves survival of septic rats through preservation of gut barrier function","volume":"37","author":"Mori","year":"2011","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jointm.2022.01.004_bib0016","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/cc8026","article-title":"Bench-to-bedside review: beta-adrenergic modulation in sepsis","volume":"13","author":"de Montmollin","year":"2009","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jointm.2022.01.004_bib0017","doi-asserted-by":"crossref","first-page":"C730","DOI":"10.1152\/ajpcell.00562.2003","article-title":"Adrenergic modulation of splenic macrophage cytokine release in polymicrobial sepsis","volume":"287","author":"Deng","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"10.1016\/j.jointm.2022.01.004_bib0018","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.resuscitation.2006.07.001","article-title":"Beta-adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis","volume":"72","author":"Schmitz","year":"2007","journal-title":"Resuscitation"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0019","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1186\/s13054-016-1580-2","article-title":"Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock","volume":"20","author":"Wei","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.jointm.2022.01.004_bib0020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fimmu.2020.01001","article-title":"The effect of \u03b2(2)-adrenoceptor agonists on leucocyte-endothelial adhesion in a rodent model of laparotomy and endotoxemia","volume":"11","author":"Bangash","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.jointm.2022.01.004_bib0021","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","article-title":"Norepinephrine dysregulates the immune response and compromises host defense during sepsis","volume":"202","author":"Stolk","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"23","key":"10.1016\/j.jointm.2022.01.004_bib0022","first-page":"e14301","article-title":"\u03b2-blockade attenuates renal blood flow in experimental endotoxic shock by reducing perfusion pressure","volume":"7","author":"van Loon","year":"2019","journal-title":"Physiol Rep"},{"issue":"19","key":"10.1016\/j.jointm.2022.01.004_bib0023","doi-asserted-by":"crossref","first-page":"e13882","DOI":"10.14814\/phy2.13882","article-title":"The influence of esmolol on right ventricular function in early experimental endotoxic shock","volume":"6","author":"van Loon","year":"2018","journal-title":"Physiol Rep"},{"issue":"16","key":"10.1016\/j.jointm.2022.01.004_bib0024","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jointm.2022.01.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/424308","article-title":"Is it time to beta block the septic patient","author":"Pemberton","year":"2015","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.jointm.2022.01.004_bib0026","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/cc13878","article-title":"Should \u03b2-blockers be used in septic shock","volume":"18","author":"Lira","year":"2014","journal-title":"Crit Care"},{"issue":"7","key":"10.1016\/j.jointm.2022.01.004_bib0027","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2014.318","article-title":"Short-acting \u03b2-blocker administration in patients with septic shock","volume":"311","author":"Bougl\u00e9","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jointm.2022.01.004_bib0028","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jama.2014.324","article-title":"Short-acting \u03b2-blocker administration in patients with septic shock","volume":"311","author":"Cort\u00e9s","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jointm.2022.01.004_bib0029","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2014.312","article-title":"Short-acting \u03b2-blocker administration in patients with septic shock","volume":"311","author":"Lin","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jointm.2022.01.004_bib0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2014.327","article-title":"Short-acting \u03b2-blocker administration in patients with septic shock \u2013 reply","volume":"311","author":"Morelli","year":"2014","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jointm.2022.01.004_bib0031","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2014.315","article-title":"Short-acting \u03b2-blocker administration in patients with septic shock","volume":"311","author":"Sanfilippo","year":"2014","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jointm.2022.01.004_bib0032","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/CCM.0000000000005034","article-title":"Association between premorbid beta-blocker exposure and sepsis outcomes \u2013 the beta-blockers in European and Australian\/American septic patients (BEAST) study","volume":"49","author":"Tan","year":"2021","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0033","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40560-021-00553-9","article-title":"Premorbid \u03b21-selective (but not non-selective) \u03b2-blocker exposure reduces intensive care unit mortality among septic patients","volume":"9","author":"Kuo","year":"2021","journal-title":"J Intensive Care"},{"issue":"6","key":"10.1016\/j.jointm.2022.01.004_bib0034","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.chest.2021.01.009","article-title":"Effect of ultrashort-acting \u03b2-blockers on mortality in patients with sepsis with persistent tachycardia despite initial resuscitation: a systematic review and meta-analysis of randomized controlled trials","volume":"159","author":"Hasegawa","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jointm.2022.01.004_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154916","article-title":"Prognosis of \u03b2-adrenergic blockade therapy on septic shock and sepsis: a systematic review and meta-analysis of randomized controlled studies","volume":"126","author":"Li","year":"2020","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.jointm.2022.01.004_bib0036","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40261-019-00762-z","article-title":"Benefits of beta-blockade in sepsis and septic shock: a systematic review","volume":"39","author":"Lee","year":"2019","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.jointm.2022.01.004_bib0037","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bja.2020.05.058","article-title":"Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction","volume":"125","author":"Morelli","year":"2020","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0038","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13054-020-03445-w","article-title":"Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study","volume":"25","author":"Levy","year":"2021","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.jointm.2022.01.004_bib0039","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/s13063-018-3024-6","article-title":"Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial","volume":"19","author":"Unger","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.jointm.2022.01.004_bib0041","first-page":"2756","article-title":"Tachycardia control in septic shock with esmolol and ivabradine: a comparison on heart function","volume":"2020","author":"Carrara","year":"2020","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.jointm.2022.01.004_bib0042","first-page":"382","article-title":"Reducing tachycardia in septic shock patients: do esmolol and ivabradine have a chronotropic effect only","volume":"2020","author":"Carrara","year":"2020","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"4","key":"10.1016\/j.jointm.2022.01.004_bib0043","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5152\/tjg.2020.19341","article-title":"Esmolol inhibits inflammation and apoptosis in the intestinal tissue via the overexpression of NF-\u03baB-p65 in the early stage sepsis rats","volume":"31","author":"Guo","year":"2020","journal-title":"Turk J Gastroenterol"},{"issue":"17","key":"10.1016\/j.jointm.2022.01.004_bib0044","first-page":"1317","article-title":"[Effect of esmolol in septic shock patients with tachycardia: a randomized clinical trial]","volume":"99","author":"Liu","year":"2019","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.jointm.2022.01.004_bib0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/1742-6723.13584","article-title":"Is lactate lower in septic patients who are prescribed beta blockers? Retrospective cohort study of an intensive care population","volume":"33","author":"Pham","year":"2021","journal-title":"Emerg Med Australas"},{"issue":"12","key":"10.1016\/j.jointm.2022.01.004_bib0046","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.ajem.2019.12.046","article-title":"Beta-blockers\u2019 effect on levels of lactate in patients with suspected sepsis \u2013 the BeLLa study","volume":"38","author":"Chan","year":"2020","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.jointm.2022.01.004_bib0047","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.chest.2020.10.049","article-title":"Comparative effectiveness of heart rate control medications for the treatment of sepsis-associated atrial fibrillation","volume":"159","author":"Bosch","year":"2021","journal-title":"Chest"}],"container-title":["Journal of Intensive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X22000214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X22000214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:01:02Z","timestamp":1763024462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667100X22000214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2667100X22000214"],"URL":"https:\/\/doi.org\/10.1016\/j.jointm.2022.01.004","relation":{},"ISSN":["2667-100X"],"issn-type":[{"value":"2667-100X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-blockers in septic shock: What is new?","name":"articletitle","label":"Article Title"},{"value":"Journal of Intensive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jointm.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}